Old	New	Differences
1	1
2	2
3	3
4	4	Req. No. 9236 Page 1 1
5	5	2
6	6	3
7	7	4
8	8	5
9	9	6
10	10	7
11	11	8
12	12	9
13	13	10
14	14	11
15	15	12
16	16	13
17	17	14
18	18	15
19	19	16
20	20	17
21	21	18
22	22	19
23	23	20
24	24	21
25	25	22
26	26	23
27	27	24
28	28	1
29	29	2
30	30	3
31	31	4
32	32	5
33	33	6
34	34	7
35	35	8
36	36	9
37	37	10
38	38	11
39	39	12
40	40	13
41	41	14
42	42	15
43	43	16
44	44	17
45	45	18
46	46	19
47	47	20
48	48	21
49	49	22
50	50	23
51	51	24
52	52
53	53	STATE OF OKLAHOMA
54	54
55	55	2nd Session of the 59th Legislature (2024)
56	56
57	57	HOUSE BILL 3733 By: Lowe (Jason)
58	58
59	59
60	60
61	61
62	62
63	63	AS INTRODUCED
64	64
65	65	An Act relating to pharmacies; amending 59 O.S. 2021,
66	66	Section 353.24, which relates to unlawful acts in the
67	67	Oklahoma Pharmacy Act ; prohibiting oral disclosur e of
68	68	medical information to third-parties; and providing
69	69	an effective date.
70	70
71	71
72	72
73	73
74	74
75	75	BE IT ENACTED BY THE PEOPLE OF T HE STATE OF OKLAHOMA:
76	76	SECTION 1. AMENDATORY 59 O.S. 2021, Section 353.24, is
77	77	amended to read as follows:
78	78	Section 353.24 A. It shall be unlawful for any licensee or
79	79	other person to:
80	80	1. Forge or increase the quantity of drug in any prescription,
81	81	or to present a prescription bearing forged, fictitious or altered
82	82	information or to possess any drug secured by such forged,
83	83	fictitious or altered prescription;
84	84	2. Sell, offer for sale, barter or give a way any unused
85	85	quantity of drugs obtained by prescription, except through a program
86	86	pursuant to the Utilization of Unused Pre scription Medications Act
87	87	or as otherwise provided by the State Board of Pharmacy;
88	88
89	89
90	90	Req. No. 9236 Page 2 1
91	91	2
92	92	3
93	93	4
94	94	5
95	95	6
96	96	7
97	97	8
98	98	9
99	99	10
100	100	11
101	101	12
102	102	13
103	103	14
104	104	15
105	105	16
106	106	17
107	107	18
108	108	19
109	109	20
110	110	21
111	111	22
112	112	23
113	113	24
114	114	1
115	115	2
116	116	3
117	117	4
118	118	5
119	119	6
120	120	7
121	121	8
122	122	9
123	123	10
124	124	11
125	125	12
126	126	13
127	127	14
128	128	15
129	129	16
130	130	17
131	131	18
132	132	19
133	133	20
134	134	21
135	135	22
136	136	23
137	137	24
138	138
139	139	3. Sell, offer for sale, barter or give away an y drugs damaged
140	140	by fire, water, or other causes without first obtaining the written
141	141	approval of the Board or the State Depar tment of Health;
142	142	4. No person, firm or business establishment shall offer to the
143	143	public, in any manner, their services as a "pick-up station" or
144	144	intermediary for the purpose of having prescriptions filled or
145	145	delivered, whether for profit or gratuitously. Nor may the owner of
146	146	any pharmacy or drug store authorize any person, firm or business
147	147	establishment to act for them in this manner with these exceptions:
148	148	a. patient-specific filled prescriptions may be delivered
149	149	or shipped to a prescriber 's clinic for pick-up by
150	150	those patients whom the prescriber has individually
151	151	determined and documented do not have a permanent or
152	152	secure mailing address,
153	153	b. patient-specific filled prescriptions for drugs which
154	154	require special handling written by a prescriber may
155	155	be delivered or shipped to the prescriber's clinic for
156	156	administration or pick-up at the prescriber 's office,
157	157	c. patient-specific filled pres criptions, including
158	158	sterile compounded drugs, may be delivered or shipped
159	159	to a prescriber's clinic where they shall be
160	160	administered,
161	161	d. patient-specific filled prescriptions for patients
162	162	with end-stage renal disease (ESRD) may be delivered
163	163
164	164
165	165	Req. No. 9236 Page 3 1
166	166	2
167	167	3
168	168	4
169	169	5
170	170	6
171	171	7
172	172	8
173	173	9
174	174	10
175	175	11
176	176	12
177	177	13
178	178	14
179	179	15
180	180	16
181	181	17
182	182	18
183	183	19
184	184	20
185	185	21
186	186	22
187	187	23
188	188	24
189	189	1
190	190	2
191	191	3
192	192	4
193	193	5
194	194	6
195	195	7
196	196	8
197	197	9
198	198	10
199	199	11
200	200	12
201	201	13
202	202	14
203	203	15
204	204	16
205	205	17
206	206	18
207	207	19
208	208	20
209	209	21
210	210	22
211	211	23
212	212	24
213	213
214	214	or shipped to a prescriber 's clinic for administration
215	215	or final delivery to the patient,
216	216	e. patient-specific filled prescriptions for
217	217	radiopharmaceuticals may be delivered or shipped to a
218	218	prescriber's clinic for administration or pick -up, or
219	219	f. patient-specific filled prescriptions may be delivered
220	220	or shipped by an Indian Health Services (IHS) or
221	221	federally recognized tribal health organization
222	222	operating under the IHS in the delivery of the
223	223	prescriptions to a pharmacy operated by the IHS or a
224	224	federally recognized tribal health organization for
225	225	pick-up by an IHS or tribal patient.
226	226	However, nothing in this paragrap h shall prevent a pharmacist or
227	227	an employee of the pharmacy from personally receiving a prescription
228	228	or delivering a legally filled prescrip tion to a residence, office
229	229	or place of employment of the patient for whom the prescription was
230	230	written. Provided f urther, the provisions of this paragr aph shall
231	231	not apply to any Department of Mental Health and Substance Abuse
232	232	Services employee or any per son whose facility contracts with the
233	233	Department of Mental Health and Substance Abuse Services whose
234	234	possession of any dangerous drug, as defined in Sect ion 353.1 of
235	235	this title, is for the purpose of delivery of a mental health
236	236	consumer's medicine to the consumer's home or residence. Nothing in
237	237	this paragraph shall prevent veterinary prescription drugs from
238	238
239	239
240	240	Req. No. 9236 Page 4 1
241	241	2
242	242	3
243	243	4
244	244	5
245	245	6
246	246	7
247	247	8
248	248	9
249	249	10
250	250	11
251	251	12
252	252	13
253	253	14
254	254	15
255	255	16
256	256	17
257	257	18
258	258	19
259	259	20
260	260	21
261	261	22
262	262	23
263	263	24
264	264	1
265	265	2
266	266	3
267	267	4
268	268	5
269	269	6
270	270	7
271	271	8
272	272	9
273	273	10
274	274	11
275	275	12
276	276	13
277	277	14
278	278	15
279	279	16
280	280	17
281	281	18
282	282	19
283	283	20
284	284	21
285	285	22
286	286	23
287	287	24
288	288
289	289	being shipped directly from an Oklahoma licensed wholesaler or
290	290	distributor registered with the Oklahoma Board of Veterinary Medical
291	291	Examiners to a client; provided, such drugs may be dispensed only on
292	292	prescription of a licensed veterinarian and only when an existing
293	293	veterinary-client-patient relationship exists. Nothing in this
294	294	paragraph shall prevent dialysate and peritoneal dialysis devices
295	295	from being shipped directly from an Oklahoma licensed manufacturer,
296	296	wholesaler or distributor to an ESRD patient or patient 's designee,
297	297	consistent with subsection F of Section 353.18 of this title;
298	298	5. Sell, offer for sale or barter or buy any professional
299	299	samples except through a program pursuant to the Utilization of
300	300	Unused Prescription Medications Act;
301	301	6. Refuse to permit o r otherwise prevent members of the Bo ard
302	302	or such representatives thereof from entering and inspecting any and
303	303	all places, including premises, vehicles, equipment, contents, and
304	304	records, where drugs, medicine, chemicals or poisons are stored,
305	305	sold, vended, given away, compounded, dispensed, re packaged,
306	306	transported, or manufactured;
307	307	7. Interfere, refuse to participate in, impede or otherwise
308	308	obstruct any inspection, investigation or disciplinary proceeding
309	309	authorized by the Oklahoma Pharmacy Act;
310	310	8. Possess dangerous drugs without a valid pr escription or a
311	311	valid license to possess such drugs; provided, however, this
312	312	provision shall not apply to a ny Department of Mental Health and
313	313
314	314
315	315	Req. No. 9236 Page 5 1
316	316	2
317	317	3
318	318	4
319	319	5
320	320	6
321	321	7
322	322	8
323	323	9
324	324	10
325	325	11
326	326	12
327	327	13
328	328	14
329	329	15
330	330	16
331	331	17
332	332	18
333	333	19
334	334	20
335	335	21
336	336	22
337	337	23
338	338	24
339	339	1
340	340	2
341	341	3
342	342	4
343	343	5
344	344	6
345	345	7
346	346	8
347	347	9
348	348	10
349	349	11
350	350	12
351	351	13
352	352	14
353	353	15
354	354	16
355	355	17
356	356	18
357	357	19
358	358	20
359	359	21
360	360	22
361	361	23
362	362	24
363	363
364	364	Substance Abuse Services employee or any person whose facility
365	365	contracts with the Department of Mental Health and Substance Abuse
366	366	Services whose possession of any dangerous drug, as defined in
367	367	Section 353.1 of this title, is for the purpose of delivery of a
368	368	mental health consumer 's medicine to the consumer 's home or
369	369	residence;
370	370	9. Fail to establish and maintain effec tive controls against
371	371	the diversion of drugs for any other purpose than legitimate
372	372	medical, scientific or in dustrial uses as provided by state, federal
373	373	and local law;
374	374	10. Fail to have a written drug diversion detectio n and
375	375	prevention policy;
376	376	11. Possess, sell, offer for sale, barter or give away any
377	377	quantity of dangerous drugs not listed as a scheduled drug pu rsuant
378	378	to Sections 2-201 through 2-212 of Title 63 of the Oklahoma Statutes
379	379	when obtained by prescription bea ring forged, fictitious or altered
380	380	information.
381	381	a. A first violation of this section shall constitute a
382	382	misdemeanor and upon conviction shall be pu nishable by
383	383	imprisonment in the county jail for a term not more
384	384	than one (1) year and a fine in an amount no t more
385	385	than One Thousand Dollars ($1, 000.00).
386	386	b. A second violation of this section shall constitute a
387	387	felony and upon conviction shall be punishabl e by
388	388
389	389
390	390	Req. No. 9236 Page 6 1
391	391	2
392	392	3
393	393	4
394	394	5
395	395	6
396	396	7
397	397	8
398	398	9
399	399	10
400	400	11
401	401	12
402	402	13
403	403	14
404	404	15
405	405	16
406	406	17
407	407	18
408	408	19
409	409	20
410	410	21
411	411	22
412	412	23
413	413	24
414	414	1
415	415	2
416	416	3
417	417	4
418	418	5
419	419	6
420	420	7
421	421	8
422	422	9
423	423	10
424	424	11
425	425	12
426	426	13
427	427	14
428	428	15
429	429	16
430	430	17
431	431	18
432	432	19
433	433	20
434	434	21
435	435	22
436	436	23
437	437	24
438	438
439	439	imprisonment in the Department of Corrections for a
440	440	term not exceeding five (5) years and a fine in an
441	441	amount not more than Two Thousand Do llars ($2,000.00);
442	442	12. Violate a Board order or agreed order;
443	443	13. Compromise the security of licensure examina tion materials;
444	444	or
445	445	14. Fail to notify the Board, in writing, within ten (10) days
446	446	of a licensee or perm it holder's address change; or
447	447	15. Disclose medical information, orally, to a customer other
448	448	than the patient prescribed the medication .
449	449	B. 1. It shall be unlawful for any person o ther than a
450	450	licensed pharmacist or physician to certify a prescription before
451	451	delivery to the patient or the patient 's representative or
452	452	caregiver. Dialysate and peritoneal dialysis devices supplied
453	453	pursuant to the provisions of subsection F of Section 35 3.18 of this
454	454	title shall not be required to be certified by a pharmacist prior to
455	455	being supplied by a manufacturer, wholesaler or distribu tor.
456	456	2. It shall be unlawf ul for any person to institute or manage a
457	457	pharmacy unless such person is a licensed pharma cist or has placed a
458	458	licensed pharmacist in charge of such pharmacy.
459	459	3. No licensed pharmacist shall manage, supervise or be in
460	460	charge of more than one pharmacy.
461	461	4. No pharmacist being requested to sell, furnish or compound
462	462	any drug, medicine, chemical o r other pharmaceutical preparat ion, by
463	463
464	464
465	465	Req. No. 9236 Page 7 1
466	466	2
467	467	3
468	468	4
469	469	5
470	470	6
471	471	7
472	472	8
473	473	9
474	474	10
475	475	11
476	476	12
477	477	13
478	478	14
479	479	15
480	480	16
481	481	17
482	482	18
483	483	19
484	484	20
485	485	21
486	486	22
487	487	23
488	488	24
489	489	1
490	490	2
491	491	3
492	492	4
493	493	5
494	494	6
495	495	7
496	496	8
497	497	9
498	498	10
499	499	11
500	500	12
501	501	13
502	502	14
503	503	15
504	504	16
505	505	17
506	506	18
507	507	19
508	508	20
509	509	21
510	510	22
511	511	23
512	512	24
513	513
514	514	prescription or otherwise, shall substit ute or cause to be
515	515	substituted for it, without authority of the prescriber or
516	516	purchaser, any like drug, medicine, chemical or pharmaceuti cal
517	517	preparation.
518	518	5. No pharmacy, pharma cist-in-charge or other person shall
519	519	permit the practice of pharmacy except by a licensed pharmacist or
520	520	assistant pharmacist.
521	521	6. No person shall subvert the authori ty of the pharmacist-in-
522	522	charge of the pharmacy by impeding the management of the
523	523	prescription department to act in complia nce with federal and state
524	524	law.
525	525	C. 1. It shall be unlawful for a pharmacy to resell dangerous
526	526	drugs to any wholesale distributor.
527	527	2. It shall be unlawful for a wholesale distribu tor to purchase
528	528	drugs from a pharmacy .
529	529	SECTION 2. This act shall become effective November 1, 2024.
530	530
531	531	59-2-9236 TJ 01/04/24

Oklahoma 2024 Regular Session

Oklahoma House Bill HB3733 Compare Versions